10-Q: iAnthus Capital Holdings Reports Net Income of $5.2 Million in Q1 2025 Amid Strategic Asset Divestitures

Sentiment:

Quarterly Report 12 May 2025 4:06 PM

📋All filings for Ianthus Capital Holdings, INC

iAnthus Capital Holdings reports a net income of $5.2 million for Q1 2025, driven by strategic asset divestitures and a focus on core markets.

Worse than expectedRevenue decreased from $41.564 million to $38.121 million year over year.

Summary

iAnthus Capital Holdings, Inc. reported net income of $5.2 million for the three months ended March 31, 2025.
The company is focusing on key markets like Florida, Maryland, New Jersey, Massachusetts, and New York.
The company divested certain assets to optimize its portfolio and strengthen its balance sheet.
Revenues for the quarter were $38.121 million, compared to $41.564 million in the same period last year.
The company had a working capital deficiency of $14.8 million as of March 31, 2025.
The company plans to redirect resources from divestments to growth initiatives and reduce debt.
The company believes it may continue to generate positive cash flows from operations in the near future.
The company completed the sale of three dispensaries and two processing/cultivation facilities in Arizona for approximately $36.5 million.
The company received $15.8 million in cash from the AZ Transaction, net of closing adjustments and tax payments, and recognized the fair value the AZ Note at $13.5 million.
The company recognized a gain on deconsolidation of $6.3 million from the AZ Transaction.
The company received approval from the Nevada Cannabis Compliance Board (NV CCB) for the NV Purchase Agreement and transfer of the licenses to the NV Buyer.
The effective closing date of the NV Closing is March 31, 2025.
The company recognized a gain of $5.7 million from the NV Closing.
The company acquired substantially all the assets related to the Cheetah Seller's wholesale business for approximately $3.5 million.
The company issued 41,667 common shares to the Cheetah Seller to satisfy the first of three tranches of common shares to be issued as part of the Cheetah Acquisition.

Sentiment

Score: 6

Explanation: The sentiment is neutral. While the company reports net income, there are concerns about working capital deficiency and going concern. Strategic divestitures and focus on core markets are positive, but the overall financial health remains uncertain.

Positives

The company reported net income of $5.2 million for Q1 2025.
The company is focusing on growth initiatives in key markets.
The company divested certain assets to optimize its portfolio and strengthen its balance sheet.
The company believes it may continue to generate positive cash flows from operations in the near future.

Negatives

The company had a working capital deficiency of $14.8 million as of March 31, 2025.
Revenues for the quarter were $38.121 million, compared to $41.564 million in the same period last year.

Risks

The substantial losses and working capital deficiency cast substantial doubt on the company's ability to continue as a going concern.
The company's business activities are illegal under U.S. federal law.
The company may be unable to raise additional funds when needed and on favorable terms.
The company's outstanding debt instruments impose certain restrictions on its operating and financing activities.

Future Outlook

The company plans to redirect resources obtained from divestments to its growth initiatives in Florida, Maryland, New Jersey, Massachusetts and New York, while still maintaining a retail presence in Arizona with one dispensary in Mesa, Arizona, as well as reduce its outstanding debt obligations. The company believes it may continue to generate positive cash flows from operations in the near future.

Industry Context

The announcement reflects a trend in the cannabis industry where companies are focusing on profitability and strategic growth by divesting non-core assets and concentrating on key markets with high growth potential. This is often driven by regulatory changes, market competition, and the need to optimize capital allocation.

Comparison to Industry Standards

Comparing iAnthus to companies like Curaleaf, Trulieve, and Green Thumb Industries, which are also multi-state operators (MSOs), iAnthus's Q1 2025 revenue of $38.121 million is significantly lower.
For example, Trulieve reported revenue of $110.7 million in Q1 2024, while Green Thumb Industries reported revenue of $275.8 million in Q1 2024.
However, iAnthus's strategic shift towards profitability through asset divestitures aligns with industry trends, as many MSOs are now prioritizing financial stability and operational efficiency over rapid expansion.
The company's focus on key markets like Florida, Maryland, New Jersey, Massachusetts, and New York mirrors the strategies of other MSOs that are concentrating their resources in states with favorable regulatory environments and high growth potential.

Legal Proceedings

The company is involved in lawsuits, claims, and proceedings, including those identified below, which arise in the ordinary course of business.
There is a claim from two former noteholders against the Company and MPX Bioceutical ULC (MPX ULC), with respect to alleged payments of $ 1.3 million made by the noteholders to MPX, claiming the right to receive $ 115.0 million.
There is a claim against the Company, MPX Bioceutical ULC ('MPX ULC') and MPX, with respect to a prior acquisition made by MPX in relation to a subsidiary that was not acquired by the Company as part of the MPX Acquisition, claiming $ 3.0 million in connection with alleged contractual obligations of MPX.
In October 2018, Craig Roberts and Beverly Roberts (the Roberts) and the Gary W. Roberts Irrevocable Trust Agreement I, Gary W. Roberts Irrevocable Trust Agreement II, and Gary W. Roberts Irrevocable Trust Agreement III (the Roberts Trust and together with the Roberts, the Roberts Plaintiffs) filed two separate but similar declaratory judgment actions in the Circuit Court of Palm Beach County, Florida against GrowHealthy Holdings, LLC (GrowHealthy Holdings) and the Company in connection with the acquisition of substantially all of GrowHealthy Holdings assets by the Company in early 2018.
On May 19, 2020, Hi-Med LLC (Hi-Med), an equity holder and one of the Unsecured Lenders who held an Unsecured Debenture in the principal amount of $ 5.0 million prior to the closing of the Recapitalization Transaction, filed a complaint (the Hi-Med Complaint) with the United States District Court for the Southern District of New York (the SDNY) against the Company and certain of the Company's current and former directors and officers and other defendants (the Hi-Med Lawsuit).
On April 20, 2020, Donald Finch, a shareholder of the Company, filed a putative class action lawsuit with the SDNY against the Company (the Class Action Lawsuit) and is seeking damages for an unspecified amount against the Company, its former Chief Executive Officer, its former Chief Financial Officer and others for alleged false and misleading statements regarding certain proceeds from the issuance of long-term debt, that were held in escrow to make interest payments in the event of default on such long-term debt.
On July 23, 2020, Blue Sky Realty Corporation filed a putative class action against the Company, the Company's former Chief Executive Officer, and the Company's Chief Financial Officer in the Ontario Superior Court of Justice ('OSCJ') in Toronto, Ontario.
On August 19, 2021, Arvin Saloum (Saloum), a former consultant of the Company, filed a Demand for Arbitration with the American Arbitration Association (the Arbitration Action) against The Healing Center Wellness Center, Inc. (THCWC) and iAnthus Arizona, LLC (iA AZ), claiming a breach of a Consulting and Joint Venture Agreement (the JV Agreement) for unpaid consulting fees allegedly owed to Saloum under the JV Agreement.
On May 23, 2022, CGX Life Sciences, Inc. (CGX), a wholly-owned subsidiary of the Company, filed a demand for arbitration (the CGX Arbitration) with the American Arbitration Association (AAA) against LMS Wellness, Benefit LLC (LMS) and its 100 % owner, William Huber (Huber and together with LMS, the Defendants) for various breaches under the option agreements entered into between CGX and LMS, on the one hand, and CGX and Huber on the other (collectively, the Option Agreements).
On June 20, 2022, Michael Weisser (Weisser) commenced a petition (the Petition) in the Court against ICH and ICH's former board of directors.

Related Party Transactions

Upon the closing of the Recapitalization Transaction, certain of the Company's lenders held greater than 5.0% of the voting interests in the Company and therefore are classified as related parties.
Pursuant to the terms of the Secured DPA, the Company has a related party payable of $6.3 million due to certain of the New Secured Lenders, including Gotham Green Fund 1, L.P., Gotham Green Fund 1 (Q), L.P., Gotham Green Fund II, L.P., Gotham Green Fund II (Q), L.P., Oasis Investment Master II Fund LTD., Senvest Global (KY), LP, Senvest Master Fund, LP and Hadron Healthcare and Consumer Special Opportunities Master Fund, for certain out-of-pocket costs, charges, fees, taxes and other expenses incurred by the New Secured Lenders in connection with the closing of the Recapitalization Transaction (the Deferred Professional Fees).

Stakeholder Impact

Shareholders: The company's strategic shift and improved financial performance may positively impact shareholder value, but the going concern warning adds uncertainty.
Employees: The company's focus on core markets may lead to job growth in those areas, while divestitures may result in job losses in divested locations.
Customers: The company's focus on core markets may lead to improved product offerings and customer service in those areas.
Creditors: The company's debt reduction efforts may improve its creditworthiness and reduce the risk of default.

Next Steps

Continue growth initiatives in Florida, Maryland, New Jersey, Massachusetts, and New York.
Maintain a retail presence in Arizona with one dispensary in Mesa, Arizona.
Reduce outstanding debt obligations.

Key Dates

Date	Description
2013-11-15	iAnthus Capital Holdings, Inc. was incorporated under the laws of British Columbia, Canada.
2017-12-08	CGX, the Company's wholly-owned subsidiary, entered into two option agreements, as amended, with LMS and Huber, the sole member of LMS, pursuant to which, CGX was granted an option to acquire 100 % ownership of LMS.
2018-10	Craig Roberts and Beverly Roberts (the Roberts) and the Gary W. Roberts Irrevocable Trust Agreement I, Gary W. Roberts Irrevocable Trust Agreement II, and Gary W. Roberts Irrevocable Trust Agreement III (the Roberts Trust and together with the Roberts, the Roberts Plaintiffs) filed two separate but similar declaratory judgment actions in the Circuit Court of Palm Beach County, Florida against GrowHealthy Holdings, LLC (GrowHealthy Holdings) and the Company in connection with the acquisition of substantially all of GrowHealthy Holdings assets by the Company in early 2018.
2019-02	Events that allegedly gave rise to the following claims, which occurred prior to the Company's closing of the MPX Bioceutical Corporation (MPX) acquisition (the MPX Acquisition) in February 2019.
2020-05-19	Hi-Med LLC (Hi-Med), an equity holder and one of the Unsecured Lenders who held an Unsecured Debenture in the principal amount of $ 5.0 million prior to the closing of the Recapitalization Transaction, filed a complaint (the Hi-Med Complaint) with the United States District Court for the Southern District of New York (the SDNY) against the Company and certain of the Company's current and former directors and officers and other defendants (the Hi-Med Lawsuit).
2020-06-24	The Company completed its previously announced recapitalization transaction (the Recapitalization Transaction) pursuant to the terms of the Restructuring Support Agreement (the Restructuring Support Agreement) dated July 10, 2020, as amended on June 15, 2021.
2021-02-02	iAnthus New Jersey, LLC ('INJ') issued an aggregate of $11.0 million of senior secured bridge notes('Senior Secured Bridge Notes').
2024-02-06	The Company entered into definitive agreements (the 'AZ Purchase Agreements') with an unaffiliated third-party buyer (the 'AZ Buyer'), pursuant to which the Company agreed to sell three dispensaries and two processing/cultivation facilities in Arizona for aggregate consideration of approximately $36.5 million (the 'AZ Transaction').
2024-02-09	ICH's wholly-owned subsidiary, Mayflower Medicinals Inc. ('Mayflower'), entered into an Asset Purchase Agreement (the 'MA Purchase Agreement') with an unaffiliated third-party buyer (the 'MA Buyer'), pursuant to which, Mayflower agreed to sell certain of its assets associated with its Holliston, Massachusetts cultivation and product manufacturing facility (the 'Purchased Assets') for $3.0 million (the 'Purchase Price').
2024-02-23	The Company's wholly-owned subsidiary, GreenMart of Nevada NLV, LLC ('GMNV') entered into an Asset Purchase Agreement (the 'NV Purchase Agreement') with an unaffiliated, third-party buyer (the 'NV Buyer'), pursuant to which, GMNV agreed to sell substantially all of the assets of GMNV to the NV Buyer.
2024-03-04	The Circuit Court for Baltimore County denied Defendants' Petition to Vacate Arbitration Award.
2024-03-20	The Company received approval from the NV CCB for the NV Purchase Agreement and transfer of the licenses to the NV Buyer.
2024-04-05	Philippe Faraut, the Company's then-Chief Financial Officer, resigned from his executive positions, including all positions with the Company's subsidiaries and affiliates.
2024-04-18	The court granted CGXs Motion to Enforce Judgment and ordered LMS and Huber to close the transaction and transfer 100% of the membership interests of LMS to CGX no later than April 21, 2025.
2024-04-21	LMS complied with the courts order and CGX now owns 100% of LMS.
2024-06-24	All operational control of GMNV was transferred to the Manager and the Company determined that it no longer had a controlling financial interest as of the NV Management Agreement Effective Date.
2024-09-27	The transaction closed on September 27, 2024 (the 'MA Closing Date').
2024-12-03	The Company and MPX ULC entered into a settlement agreement with the parties to this litigation, pursuant to which, the parties thereto agreed to settle this matter on terms that provide for, among other things, a cash payment of approximately CAD$ 0.5 million and the issuance of 5,000,000 common shares of the Company to the plaintiff, at a deemed price of CAD$ 0.01 per share.
2024-12-30	The Company entered into an Asset Purchase Agreement (the 'Cheetah Purchase Agreement') with Cheetah Enterprises, Inc. (the 'Cheetah Seller'), pursuant to which, the Company acquired substantially all the assets related to the Cheetah Seller's wholesale business.
2025-01-09	The Company issued common shares totaling 41,667 with respect to the Cheetah Acquisition (Refer to Note 4).
2025-01-14	The Company issued 26,661 common shares for vested restricted stock units (RSUs).
2025-02-05	The Company entered into consent and release agreement with Secured Lenders to utilize cash proceeds upon the closing of the AZ Transaction to payments in the amount of $ 5.0 million towards the principal amount outstanding under the Deferred Professional Fees.
2025-02-10	The AZ Transaction closed on February 14, 2025, with an effective closing date of February 10, 2025, which is the date the AZ Buyer assumed the financial benefit and risk relating to the AZ Purchased Assets.
2025-03-04	The MCA approved the transfer of 100 % of the ownership of LMS to CGX.
2025-03-07	LMS filed an action in the Circuit Court for Anne Arundel County, seeking a writ of mandamus, temporary restraining order and preliminary injunction against the MCA on the basis that the MCA violated the law by issuing its March 4, 2025 approval regarding the transfer of 100 % of the ownership of LMS to CGX.
2025-03-20	The Company received approval from the NV CCB for the NV Purchase Agreement and transfer of the licenses to the NV Buyer.
2025-03-31	The effective closing date of the NV Closing is March 31, 2025.
2025-04-01	The Company issued 146 common shares for vested RSUs to certain employees.
2025-04-21	LMS complied with the courts order and CGX now owns 100% of LMS.
2025-04-23	The Company withheld 9,910 common shares for vested RSUs to a certain director to satisfy tax obligations of $0.1 million.
2025-05-05	Number of common shares outstanding as of May 5, 2025 was 6,735,929,933.
2025-05-12	Date of report.

Keywords

cannabis, ianthus, divestiture, acquisition, financial results, capital holdings, net income, revenue

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.